Trial Profile
Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Desloratadine Tablet Among Filipino Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary)
- Indications Allergic rhinitis; Urticaria
- Focus Adverse reactions
- Sponsors Organon
- 22 Jul 2009 Actual patient number (3011) added as reported by ClinicalTrials.gov.
- 01 Oct 2008 Actual end date (1 Dec 2007) added as reported by ClinicalTrials.gov.
- 01 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.